Cancer Targeted Technology (CTT)
Cancer Targeted Technology (CTT) is a biotechnology firm developing cancer diagnostics and therapeutics. Their current focus is on CTT2274, a novel prodrug targeting Prostate-Specific Membrane Antigen (PSMA) for the treatment of metastatic prostate cancer. This prodrug offers a unique approach with improved efficacy and reduced side effects compared to existing treatments.
Buy Funded Startups lists
Funding Round: Grant
Funding Amount: $2.4M
Date: 18-Nov-2024
Investors: National Cancer Institute
Markets: Biotechnology, Oncology, Therapeutics
HQ: Seattle, Washington, United States
Founded:
Leave a Comment
Comments
No comments yet.